UK markets closed

TaiMed Biologics Inc. (4147.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
90.90-0.10 (-0.11%)
At close: 01:30PM CST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-130,044
-194,810
-269,289
-470,933
-183,304
-
Depreciation & amortisation
155,016
155,387
156,446
156,660
139,782
-
Stock-based compensation
24,937
10,511
12,267
10,222
16,680
-
Change in working capital
-21,113
-31,555
-796,285
-6,023
-230,563
-
Inventory
125,919
110,850
-382,841
14,839
-384,988
-
Other working capital
80,330
-31,753
-609,971
-224,835
-586,463
-
Other non-cash items
35,733
9,405
5,761
79,936
-2,937
-
Net cash provided by operating activities
85,769
-25,601
-605,210
-211,275
-201,936
-
Cash flows from investing activities
Investments in property, plant and equipment
-5,439
-6,152
-4,761
-13,560
-384,527
-
Purchases of investments
-102,369
-43,386
0
-18,230
-16,613
-
Sales/maturities of investments
192
30,503
110,876
222,300
289,977
-
Other investing activities
-
2,580
-
-
-
166
Net cash used for investing activities
-105,126
-16,455
106,115
190,920
-109,163
-
Net change in cash
1,637,523
-23,103
-277,508
-20,472
219,156
-
Cash at beginning of period
225,905
274,110
551,618
572,090
352,934
-
Cash at end of period
1,855,465
251,007
274,110
551,618
572,090
-
Free cash flow
Operating cash flow
85,769
-25,601
-605,210
-211,275
-201,936
-
Capital expenditure
-5,439
-6,152
-4,761
-13,560
-384,527
-
Free cash flow
80,330
-31,753
-609,971
-224,835
-586,463
-